I am truly glad to be part of this clinical research community that looks for opportunities and drives for excellence and innovation. Thanks to multiple conversations with my network of experts I can see signs of change. And because I believe that change comes from people, I am writing this …
Patient recruitment is the most challenging aspect of a clinical trial. According to the latest research, it’s also the main reason for delays in 85% of the studies. Planning and predicting recruitment is a major focus of every sponsor company and in turn, of every CRO. But can patient recruitment …
Predicting Patient Recruitment: The Goal of Every Sponsor and CRO Read More »
Clinical Research Organizations (CRO) are the experts in clinical trial feasibility and the go-to-partner for helping biotech and pharma companies research, evaluate and launch their novel compound or medical device. And in fact, the CRO market has been growing in the last few years and is expected to reach $44bln …
Planning a Clinical Trial: 3 Factors CROs Consider That Sponsors Rarely Do Read More »
Recently, Maya Zlatanova’s article Decentralized Clinical Trials Across Europe: Regulatory and Other Practical Considerations was published in DIA’s Global Forum. The piece highlights the most important considerations for planning and conducting decentralized clinical trials in Europe – from the different ‘readings’ of EMA’s guidelines depending on the country to the mindset of the patients depending …
The One Thing Your Decentralized Clinical Trial Strategy Is Missing Read More »
Planning a clinical trial means juggling and balancing multiple factors and priorities. In fact, a successful trial is so much more than managing data, sites, patients and hoping for a fruitful outcome. Pharma and biotech companies need to ensure that their future trial is in alignment with internal and external …
CROs: How to Go From an RFP to a Bid Defense to Winning the Project Read More »
Everyone who has been involved in the planning of a clinical trial knows the difficulty of considering every stakeholder. Keeping a good balance for your trial success is like juggling. So, why would you want to add another “ball” in the air? It depends on the “ball” you add to …
Recently, I had a chat with a friend of mine who works at a top 10 CRO and was telling me about one of the last clinical trials he was managing. It was for an indication that is quite “popular” in clinical trials nowadays. He was a part of the …
Not Enrolling Patients? The One Explanation You Haven’t Considered Yet Read More »
“Look Before You Leap” is unsurprisingly the principle that all clinical trial sponsors follow. After all, a clinical trial, while being a hundreds of millions or even billions of dollars risk, hopefully, will result in the release of a new compound/treatment to the market. That new product might be the …
When my team and I set out to simplify the way feasibility and biz dev teams run RFPs and plan their clinical trials we had numerous conversations with medical directors and feasibility experts to make sure we understand their processes and align with their KPIs. Our goal was to create …
